vs
ESSENTIAL PROPERTIES REALTY TRUST, INC.（EPRT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是ESSENTIAL PROPERTIES REALTY TRUST, INC.的1.3倍（$207.3M vs $158.8M），ESSENTIAL PROPERTIES REALTY TRUST, INC.净利率更高（37.8% vs -62.0%，领先99.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 22.8%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 20.6%）
Essential Properties Realty Trust是一家上市房地产投资信托企业，收购、持有并管理美国全境的单租户净租赁商业地产组合，资产主要覆盖休闲餐饮、汽车服务、医疗诊所、幼儿教育中心、轻型工业等刚需服务类业态，租户普遍拥有稳健的长期经营记录。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
EPRT vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $158.8M | $207.3M |
| 净利润 | $60.0M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 56.5% | -54.7% |
| 净利率 | 37.8% | -62.0% |
| 营收同比 | 22.8% | 25.9% |
| 净利润同比 | 6.5% | 3.5% |
| 每股收益（稀释后） | $0.28 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $158.8M | — | ||
| Q4 25 | $149.9M | $207.3M | ||
| Q3 25 | $144.9M | $159.9M | ||
| Q2 25 | $137.1M | $166.5M | ||
| Q1 25 | $129.4M | $139.3M | ||
| Q4 24 | $119.7M | $164.6M | ||
| Q3 24 | $117.1M | $139.5M | ||
| Q2 24 | $109.3M | $147.0M |
| Q1 26 | $60.0M | — | ||
| Q4 25 | $68.1M | $-128.6M | ||
| Q3 25 | $65.6M | $-180.4M | ||
| Q2 25 | $63.2M | $-115.0M | ||
| Q1 25 | $56.1M | $-151.1M | ||
| Q4 24 | $55.4M | $-133.2M | ||
| Q3 24 | $49.1M | $-133.5M | ||
| Q2 24 | $51.5M | $-131.6M |
| Q1 26 | 56.5% | — | ||
| Q4 25 | 65.9% | -54.7% | ||
| Q3 25 | 64.7% | -106.9% | ||
| Q2 25 | 64.1% | -64.8% | ||
| Q1 25 | 61.6% | -102.6% | ||
| Q4 24 | 66.1% | -74.3% | ||
| Q3 24 | 59.7% | -94.6% | ||
| Q2 24 | 61.1% | -79.1% |
| Q1 26 | 37.8% | — | ||
| Q4 25 | 45.4% | -62.0% | ||
| Q3 25 | 45.3% | -112.8% | ||
| Q2 25 | 46.1% | -69.0% | ||
| Q1 25 | 43.4% | -108.5% | ||
| Q4 24 | 46.3% | -80.9% | ||
| Q3 24 | 42.0% | -95.7% | ||
| Q2 24 | 47.1% | -89.5% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.34 | $-1.28 | ||
| Q3 25 | $0.33 | $-1.81 | ||
| Q2 25 | $0.32 | $-1.17 | ||
| Q1 25 | $0.29 | $-1.57 | ||
| Q4 24 | $0.31 | $-1.34 | ||
| Q3 24 | $0.27 | $-1.40 | ||
| Q2 24 | $0.29 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.2M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.4B | $-80.0M |
| 总资产 | $7.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $15.2M | — | ||
| Q4 25 | $60.2M | $421.0M | ||
| Q3 25 | $23.8M | $202.5M | ||
| Q2 25 | $20.8M | $176.3M | ||
| Q1 25 | $47.0M | $127.1M | ||
| Q4 24 | $40.7M | $174.0M | ||
| Q3 24 | $32.7M | $150.6M | ||
| Q2 24 | $23.6M | $480.7M |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $1.9B | — |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $4.2B | $-80.0M | ||
| Q3 25 | $3.8B | $9.2M | ||
| Q2 25 | $3.8B | $151.3M | ||
| Q1 25 | $3.8B | $144.2M | ||
| Q4 24 | $3.6B | $255.0M | ||
| Q3 24 | $3.2B | $346.8M | ||
| Q2 24 | $3.2B | $432.4M |
| Q1 26 | $7.2B | — | ||
| Q4 25 | $6.9B | $1.5B | ||
| Q3 25 | $6.6B | $1.2B | ||
| Q2 25 | $6.3B | $1.3B | ||
| Q1 25 | $6.1B | $1.3B | ||
| Q4 24 | $5.8B | $1.5B | ||
| Q3 24 | $5.5B | $1.5B | ||
| Q2 24 | $5.3B | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $381.1M | $-99.8M | ||
| Q3 25 | $99.0M | $-91.4M | ||
| Q2 25 | $99.8M | $-108.3M | ||
| Q1 25 | $77.2M | $-166.5M | ||
| Q4 24 | $308.5M | $-79.3M | ||
| Q3 24 | $73.5M | $-67.0M | ||
| Q2 24 | $81.1M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 5.60× | — | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 1.38× | — | ||
| Q4 24 | 5.57× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
